Healthcare upgrades and initiations for Tuesday


BofA upgrades Perrigo (PRGO +1.2%) to Buy from Neutral. RBC starts the shares as a Top Pick, with a $187 price target.

BofA upgrades Becton Dickinson (BDX +0.8%) to Neutral from Underperform.

RBC upgrades Johnson & Johnson (JNJ +1.6%) to Outperform from Sector Perform. Price target is $104.

Citi upgrades Varian Medical (VAR +1.6%) to Neutral from Sell.

Roth starts ANI Pharma (ANIP +9.5%) at Buy. Price target is $27.

RBC starts Teva (TEVA +0.1%) at Sector Perform. Price target is $39.

RBC starts AcelRx (ACRX +2.5%) at Outperform. Price target is $15.

RBC starts Mylan (MYL +2.3%) at Outperform. Price target is $50.

RBC starts Allergan (AGN +1.3%) at Outperform. Price target is $131.

RBC starts Impax Labs (IPXL +0.2%) at Sector Perform. Price target is $25.

From other sites
Comments (3)
  • doc47
    , contributor
    Comments (1671) | Send Message
     
    "RBC starts Teva (TEVA +0.1%) at Sector Perform. Price target is $39." Not exactly an earth-shattering call here!
    7 Jan 2014, 10:20 AM Reply Like
  • vcccd
    , contributor
    Comments (74) | Send Message
     
    Target 39? closed at 41.72 today. Targeting downward?
    7 Jan 2014, 09:39 PM Reply Like
  • vcccd
    , contributor
    Comments (74) | Send Message
     
    Target 29? It closed at 41.72 today. Targeting downward?
    7 Jan 2014, 09:39 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs